Month: May 2024 (Page 32)

On:

Medical marijuana businesses and regulators in Georgia are cheering last week’s announcement that the federal Drug Enforcement Administration (DEA) will move cannabis to Schedule III of the Controlled Substances Act (CSA). They say the change could expand patients’ access to marijuana through pharmacies, whereas it is currently available through justContinue Reading

On:

Big Marijuana is the only winner with rescheduling Image Cannabis News May 7, 2024 The Rise of Big Marijuana: Who Really Wins with Federal Rescheduling? Last week the Biden administration recommended marijuana be rescheduled from a Schedule I to a Schedule III drug, and it sent the marijuana investment marketsContinue Reading

On:

The head of the Drug Enforcement Administration (DEA) told lawmakers on Tuesday that it would be “inappropriate” for her to comment on the agency’s recent marijuana rescheduling determination because the rulemaking process is “ongoing.” About a week after the Justice Department confirmed DEA is seeking to move cannabis from ScheduleContinue Reading

On:

Sen. Nelson amendments would add consumer protections to Cannabis law Image Cannabis News May 7, 2024 Minnesota State Senator Introduces Amendments to Strengthen Cannabis Law Protections. Minnesota State Senator Carla Nelson (R-Rochester) on Friday successfully added four amendments to a Senate bill proposing several changes to the state’s cannabis law.Continue Reading

On:

New York’s Cannabis applicants deserve more transparency Image Cannabis News May 7, 2024 Last month, a Harvard Medical School article described exactly what you are going through right now. It says, “A stressful situation — whether something environmental, such as a looming work deadline, or psychological, such as persistent worryContinue Reading

On:

DEA Administrator Allegedly Absent from Cannabis Rescheduling Decision Image Cannabis News May 7, 2024 Confusion Surrounds DEA Administrator’s Role in Cannabis Rescheduling Decision. Reports from last week suggesting that the US Drug Enforcement Administration (DEA) would support recommendations for cannabis rescheduling were not approved by the organization’s administrator, one sourceContinue Reading